| Year |
Citation |
Score |
| 2011 |
Rak JW, Magnus N, Garnier D, D’Asti E, Hashemi M, Meehan B, Milsom C, Yu JL. Oncogenic Regulation of Tissue Factor Expression Blood. 118: SCI-16-SCI-16. DOI: 10.1182/Blood.V118.21.Sci-16.Sci-16 |
0.527 |
|
| 2010 |
Yu JL, Xing R, Milsom C, Rak J. Modulation of the oncogene-dependent tissue factor expression by kinase suppressor of ras 1. Thrombosis Research. 126: e6-10. PMID 20553947 DOI: 10.1016/J.Thromres.2010.04.014 |
0.473 |
|
| 2010 |
Garnier D, Milsom C, Magnus N, Meehan B, Weitz J, Yu J, Rak J. Role of the tissue factor pathway in the biology of tumor initiating cells. Thrombosis Research. 125: S44-50. PMID 20434004 DOI: 10.1016/S0049-3848(10)70012-8 |
0.428 |
|
| 2008 |
Milsom CC, Yu JL, Mackman N, Micallef J, Anderson GM, Guha A, Rak JW. Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis. Cancer Research. 68: 10068-76. PMID 19074872 DOI: 10.1158/0008-5472.Can-08-2067 |
0.569 |
|
| 2008 |
Rak J, Milsom C, Yu J. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role? Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. 116: 660-76. PMID 18834410 DOI: 10.1111/j.1600-0463.2008.01058.x |
0.392 |
|
| 2008 |
Yu J, May L, Milsom C, Anderson GM, Weitz JI, Luyendyk JP, Broze G, Mackman N, Rak J. Contribution of host-derived tissue factor to tumor neovascularization. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 1975-81. PMID 18772494 DOI: 10.1161/Atvbaha.108.175083 |
0.422 |
|
| 2008 |
Milsom C, Yu J, May L, Magnus N, Rak J. Diverse roles of tissue factor-expressing cell subsets in tumor progression. Seminars in Thrombosis and Hemostasis. 34: 170-81. PMID 18645922 DOI: 10.1055/s-2008-1079257 |
0.495 |
|
| 2007 |
Milsom C, Yu J, May L, Meehan B, Magnus N, Al-Nedawi K, Luyendyk J, Weitz J, Klement P, Broze G, Mackman N, Rak J. The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression. Thrombosis Research. 120: S82-91. PMID 18023719 DOI: 10.1016/S0049-3848(07)70135-4 |
0.525 |
|
| 2007 |
Klement H, St Croix B, Milsom C, May L, Guo Q, Yu JL, Klement P, Rak J. Atherosclerosis and vascular aging as modifiers of tumor progression, angiogenesis, and responsiveness to therapy. The American Journal of Pathology. 171: 1342-51. PMID 17823292 DOI: 10.2353/Ajpath.2007.070298 |
0.564 |
|
| 2006 |
Rak J, Yu JL, Luyendyk J, Mackman N. Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans. Cancer Research. 66: 10643-6. PMID 17108099 DOI: 10.1158/0008-5472.Can-06-2350 |
0.439 |
|
| 2006 |
Rak J, Milsom C, May L, Klement P, Yu J. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Seminars in Thrombosis and Hemostasis. 32: 54-70. PMID 16479463 DOI: 10.1055/s-2006-933341 |
0.504 |
|
| 2005 |
Kalas W, Yu JL, Milsom C, Rosenfeld J, Benezra R, Bornstein P, Rak J. Oncogenes and Angiogenesis: down-regulation of thrombospondin-1 in normal fibroblasts exposed to factors from cancer cells harboring mutant ras. Cancer Research. 65: 8878-86. PMID 16204059 DOI: 10.1158/0008-5472.Can-05-1479 |
0.436 |
|
| 2005 |
Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz JI, Coomber BL, Mackman N, Rak JW. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood. 105: 1734-41. PMID 15494427 DOI: 10.1182/Blood-2004-05-2042 |
0.5 |
|
| 2004 |
Yu JL, May L, Klement P, Weitz JI, Rak J. Oncogenes as regulators of tissue factor expression in cancer: implications for tumor angiogenesis and anti-cancer therapy. Seminars in Thrombosis and Hemostasis. 30: 21-30. PMID 15034795 DOI: 10.1055/S-2004-822968 |
0.579 |
|
| 2004 |
Rak J, Yu JL. Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand". Seminars in Cancer Biology. 14: 93-104. PMID 15018893 DOI: 10.1016/J.Semcancer.2003.09.014 |
0.59 |
|
| 2003 |
Kalas W, Gilpin S, Yu JL, May L, Krchnakova H, Bornstein P, Rak J. Restoration of thrombospondin 1 expression in tumor cells harbouring mutant ras oncogene by treatment with low doses of doxycycline. Biochemical and Biophysical Research Communications. 310: 109-14. PMID 14511656 DOI: 10.1016/J.Bbrc.2003.08.128 |
0.481 |
|
| 2003 |
Viloria-Petit A, Miquerol L, Yu JL, Gertsenstein M, Sheehan C, May L, Henkin J, Lobe C, Nagy A, Kerbel RS, Rak J. Contrasting effects of VEGF gene disruption in embryonic stem cell-derived versus oncogene-induced tumors. The Embo Journal. 22: 4091-102. PMID 12912908 DOI: 10.1093/Emboj/Cdg408 |
0.725 |
|
| 2003 |
Coomber BL, Yu JL, Fathers KE, Plumb C, Rak JW. Angiogenesis and the role of epigenetics in metastasis. Clinical & Experimental Metastasis. 20: 215-27. PMID 12741680 DOI: 10.1023/A:1022935117193 |
0.571 |
|
| 2003 |
Yu JL, Rak JW. Host microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Research : Bcr. 5: 83-8. PMID 12631386 DOI: 10.1186/Bcr573 |
0.364 |
|
| 2003 |
Goertz DE, Yu JL, Kerbel RS, Burns PN, Foster FS. High-frequency 3-D color-flow imaging of the microcirculation. Ultrasound in Medicine & Biology. 29: 39-51. PMID 12604116 DOI: 10.1016/s0301-5629(02)00682-8 |
0.422 |
|
| 2002 |
Yu JL, Coomber BL, Kerbel RS. A paradigm for therapy-induced microenvironmental changes in solid tumors leading to drug resistance. Differentiation; Research in Biological Diversity. 70: 599-609. PMID 12492501 DOI: 10.1046/J.1432-0436.2002.700913.X |
0.679 |
|
| 2002 |
Goertz DE, Yu JL, Kerbel RS, Burns PN, Foster FS. High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow. Cancer Research. 62: 6371-5. PMID 12438217 |
0.555 |
|
| 2002 |
Rak J, Yu JL, Kerbel RS, Coomber BL. What do oncogenic mutations have to do with angiogenesis/vascular dependence of tumors? Cancer Research. 62: 1931-4. PMID 11929804 |
0.611 |
|
| 2002 |
Tran J, Master Z, Yu JL, Rak J, Dumont DJ, Kerbel RS. A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proceedings of the National Academy of Sciences of the United States of America. 99: 4349-54. PMID 11917134 DOI: 10.1073/Pnas.072586399 |
0.727 |
|
| 2002 |
Yu JL, Rak JW, Klement G, Kerbel RS. Vascular endothelial growth factor isoform expression as a determinant of blood vessel patterning in human melanoma xenografts. Cancer Research. 62: 1838-46. PMID 11912163 |
0.658 |
|
| 2002 |
Yu JL, Rak JW, Coomber BL, Hicklin DJ, Kerbel RS. Effect of p53 status on tumor response to antiangiogenic therapy. Science (New York, N.Y.). 295: 1526-8. PMID 11859195 DOI: 10.1126/Science.1068327 |
0.623 |
|
| 2001 |
Kerbel RS, Yu J, Tran J, Man S, Viloria-Petit A, Klement G, Coomber BL, Rak J. Possible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approaches. Cancer Metastasis Reviews. 20: 79-86. PMID 11831651 DOI: 10.1023/A:1013172910858 |
0.689 |
|
| 2001 |
Yu JL, Rak JW, Carmeliet P, Nagy A, Kerbel RS, Coomber BL. Heterogeneous vascular dependence of tumor cell populations. The American Journal of Pathology. 158: 1325-34. PMID 11290550 DOI: 10.1016/S0002-9440(10)64083-7 |
0.64 |
|
| 2000 |
Rak J, Yu JL, Klement G, Kerbel RS. Oncogenes and angiogenesis: signaling three-dimensional tumor growth. The Journal of Investigative Dermatology. Symposium Proceedings / the Society For Investigative Dermatology, Inc. [and] European Society For Dermatological Research. 5: 24-33. PMID 11147671 DOI: 10.1046/j.1087-0024.2000.00012.x |
0.682 |
|
| 2000 |
Goertz DE, Christopher DA, Yu JL, Kerbel RS, Burns PN, Foster FS. High-frequency color flow imaging of the microcirculation. Ultrasound in Medicine & Biology. 26: 63-71. PMID 10687794 DOI: 10.1016/S0301-5629(99)00101-5 |
0.484 |
|
| Show low-probability matches. |